BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 10785223)

  • 41. Serum inhibin A, inhibin B, and pro-alphaC levels are altered after surgically or pharmacologically induced menopause.
    Cobellis L; Luisi S; Pezzani I; Reis FM; De Leo V; Petraglia F
    Fertil Steril; 2002 Apr; 77(4):745-9. PubMed ID: 11937127
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Inhibin secretion in women with the polycystic ovary syndrome before and after treatment with progesterone.
    Dafopoulos K; Venetis C; Messini CI; Pournaras S; Anifandis G; Garas A; Messinis IE
    Reprod Biol Endocrinol; 2011 Apr; 9():59. PubMed ID: 21529351
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Acute effects of metformin therapy include improvement of insulin resistance and ovarian morphology.
    Bayrak A; Terbell H; Urwitz-Lane R; Mor E; Stanczyk FZ; Paulson RJ
    Fertil Steril; 2007 Apr; 87(4):870-5. PubMed ID: 17224152
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Elevated serum levels of free insulin-like growth factor I in polycystic ovary syndrome.
    Thierry van Dessel HJ; Lee PD; Faessen G; Fauser BC; Giudice LC
    J Clin Endocrinol Metab; 1999 Sep; 84(9):3030-5. PubMed ID: 10487660
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Serum inhibin A and inhibin B in healthy prepubertal, pubertal, and adolescent girls and adult women: relation to age, stage of puberty, menstrual cycle, follicle-stimulating hormone, luteinizing hormone, and estradiol levels.
    Sehested A; Juul AA; Andersson AM; Petersen JH; Jensen TK; Müller J; Skakkebaek NE
    J Clin Endocrinol Metab; 2000 Apr; 85(4):1634-40. PubMed ID: 10770209
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Biphasic increase in serum inhibin B during puberty: a longitudinal study of healthy Finnish boys.
    Raivio T; Perheentupa A; McNeilly AS; Groome NP; Anttila R; Siimes MA; Dunkel L
    Pediatr Res; 1998 Oct; 44(4):552-6. PubMed ID: 9773845
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Obesity differentially affects serum levels of androstenedione and testosterone in polycystic ovary syndrome.
    Moran C; Renteria JL; Moran S; Herrera J; Gonzalez S; Bermudez JA
    Fertil Steril; 2008 Dec; 90(6):2310-7. PubMed ID: 18163993
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Body weight, hyperinsulinemia, and gonadotropin levels in the polycystic ovarian syndrome: evidence of two distinct populations.
    Dale PO; Tanbo T; Vaaler S; Abyholm T
    Fertil Steril; 1992 Sep; 58(3):487-91. PubMed ID: 1521640
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Serum inhibin A concentration in women with polycystic ovarian syndrome and the correlation to ethnicity, androgens and insulin resistance.
    Segal S; Elmadjian M; Takeshige T; Karp S; Mercado R; Rivnay B
    Reprod Biomed Online; 2010 May; 20(5):675-80. PubMed ID: 20231113
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Do basal inhibin A and inhibin B levels have value in the diagnosis of polycystic ovary syndrome?
    Torgac M; Kokcu A; Cetinkaya MB; Alper T; Malatyalioglu E
    Gynecol Endocrinol; 2005 Jun; 20(6):322-6. PubMed ID: 16019381
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Aberrantly increased mRNA expression of betaglycan, an inhibin co-receptor in the ovarian tissues in women with polycystic ovary syndrome.
    Zhu R; Zhou X; Chen Y; Qiu C; Xu W; Shen Z
    J Obstet Gynaecol Res; 2010 Feb; 36(1):138-46. PubMed ID: 20178540
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Determination of insulin resistance and its relationship with hyperandrogenemia,anti-Müllerian hormone, inhibin A, inhibin B, and insulin-like peptide-3 levels in adolescent girls with polycystic ovary syndrome.
    Yetim Şahin A; Baş F; Yetim Ç; Uçar A; Poyrazoğlu Ş; Bundak R; Darendeliler F
    Turk J Med Sci; 2019 Aug; 49(4):1117-1125. PubMed ID: 31286756
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The association of body mass index and biochemical hyperandrogenaemia in women with and without polycystic ovary syndrome.
    Yasmin E; Balen AH; Barth JH
    Eur J Obstet Gynecol Reprod Biol; 2013 Feb; 166(2):173-7. PubMed ID: 23102586
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Augmented frequency and mass of LH discharged per burst are accompanied by marked disorderliness of LH secretion in adolescents with polycystic ovary syndrome.
    García-Rudaz MC; Ropelato MG; Escobar ME; Veldhuis JD; Barontini M
    Eur J Endocrinol; 1998 Dec; 139(6):621-30. PubMed ID: 9916868
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Luteal-phase inhibin A and follicular-phase inhibin B levels are not characteristic of patients with an elevated LH-to-FSH ratio.
    Hauzman EE; Fancsovits P; Murber A; Rabe T; Strowitzki T; Papp Z; Urbancsek J
    J Assist Reprod Genet; 2006 Mar; 23(3):141-7. PubMed ID: 16758344
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Evaluation of the pro-inflammatory cytokine tumor necrosis factor-α in adolescents with polycystic ovary syndrome.
    Pawelczak M; Rosenthal J; Milla S; Liu YH; Shah B
    J Pediatr Adolesc Gynecol; 2014 Dec; 27(6):356-9. PubMed ID: 25256873
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Metastin levels in relation with hormonal and metabolic profile in patients with polycystic ovary syndrome.
    Yilmaz SA; Kerimoglu OS; Pekin AT; Incesu F; Dogan NU; Celik C; Unlu A
    Eur J Obstet Gynecol Reprod Biol; 2014 Sep; 180():56-60. PubMed ID: 25020276
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Anti-Mullerian hormone levels reflect severity of PCOS but are negatively influenced by obesity: relationship with increased luteinizing hormone levels.
    Piouka A; Farmakiotis D; Katsikis I; Macut D; Gerou S; Panidis D
    Am J Physiol Endocrinol Metab; 2009 Feb; 296(2):E238-43. PubMed ID: 18957615
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Elevated serum level of anti-mullerian hormone in patients with polycystic ovary syndrome: relationship to the ovarian follicle excess and to the follicular arrest.
    Pigny P; Merlen E; Robert Y; Cortet-Rudelli C; Decanter C; Jonard S; Dewailly D
    J Clin Endocrinol Metab; 2003 Dec; 88(12):5957-62. PubMed ID: 14671196
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Serum anti-Müllerian hormone and inhibin B concentrations are not useful predictors of ovarian response during ovulation induction treatment with recombinant follicle-stimulating hormone in women with polycystic ovary syndrome.
    Lie Fong S; Schipper I; de Jong FH; Themmen AP; Visser JA; Laven JS
    Fertil Steril; 2011 Aug; 96(2):459-63. PubMed ID: 21719005
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.